Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
68.61
-0.22 (-0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Pick These 4 Stocks With Exciting Interest Coverage Ratio
November 26, 2022
Let's take a look at some of the companies that boast an impressive interest coverage ratio.
Via
Talk Markets
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today
November 23, 2022
Via
Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
This Is What Whales Are Betting On Gilead Sciences
November 22, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
November 22, 2022
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
Via
The Motley Fool
Gilead Sciences' Debt Overview
November 21, 2022
Shares of Gilead Sciences' Inc. (NASDAQ:GILD) rose by 33.62% in the past three months. Before we understand the importance of debt, let's look at how much debt Gilead Sciences' has.
Via
Benzinga
Has This Hot Stock Run Out of Steam?
November 10, 2022
Shares of Gilead Sciences have been have been on a tear recently.
Via
The Motley Fool
Why Shares of Gilead Sciences Rose 27.20% in October
November 08, 2022
The company's growing oncology portfolio is driving increased revenues.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Circle. This hedge fund uses a quantitative...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16
November 16, 2022
Benzinga
Via
Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Via
Benzinga
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily...
Via
Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
Both of these companies have potential catalysts on the way.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years
November 08, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 8.27% on an annualized basis producing an average annual return of 15.72%. Currently, Gilead Sciences has a market...
Via
Benzinga
Gilead Sciences Unusual Options Activity
November 08, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
US Supreme Court Throws Out Bristol Myers Appeal On Cancer-Drug Related Patent With Gilead
November 07, 2022
Via
Benzinga
3 No-Brainer Dividend Stocks to Buy in November
November 05, 2022
There's no need for agonizing decision-making with these great dividend stocks.
Via
The Motley Fool
G1 Therapeutics Says Its Lead Candidate May Cut Adverse Events Of Gilead's Breast Cancer Drug
November 02, 2022
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
November 01, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biogen To Rally Around 15%? Here Are 5 Other Price Target Changes For Tuesday
November 01, 2022
Mizuho raised Biogen Inc. (NASDAQ: BIIB) price target from $270 to $325. Mizuho analyst Salim Syed maintained the stock with a Buy rating. Biogen shares fell 0.3% to close at $283.44 on Monday.
Via
Benzinga
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
A Look Into Gilead Sciences's Debt
October 31, 2022
Over the past three months, shares of Gilead Sciences Inc. (NASDAQ:GILD) rose by 26.52%. Before we understand the importance of debt, let's look at how much debt Gilead Sciences has.
Via
Benzinga
Healthcare & Biotech Stocks: A Big Opportunity In 2023
October 30, 2022
One of the areas that will come with opportunities for stock market investors in 2023 is the health care sector. This includes pharma, medical devices, biotech, and the likes.
Via
Talk Markets
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
October 31, 2022
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Via
Benzinga
These 2 Stock Winners Topped Apple's Big Gains Friday
October 28, 2022
Strong earnings helped lift the market.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Check Out What Whales Are Doing With GILD
October 28, 2022
Someone with a lot of money to spend has taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.